New Topographic Classification of Knee Bone Marrow Lesions

Knee Bone Marrow Lesions Clinical Trial

— ncbe  

Official title:

Validation of a New Topographic Classification of Bone Marrow Lesions of the Knee

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03976141
• Other study ID #: ncbe
• Status: Completed
• Start date: May 14, 2019
• Est. completion date: April 30, 2020

Study information

• Verified date: November 2020
• Source: University of Milan
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

the investigator are studying a new topographic classification of bone marrow lesion in the knee and validating it.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 500
• Est. completion date: April 30, 2020
• Est. primary completion date: May 30, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• age over 18 with mri with lesion consent given

Exclusion Criteria:

• under mri previous surgery tumors no consent

Related Conditions & MeSH terms

• Knee Bone Marrow Lesions

Intervention

Diagnostic Test:
• mri
knee mri

Locations

Country	Name	City	State
Italy	2) 1° Clinica Ortopedica, ASST Centro Specialistico Ortopedico Traumatologico Gaetano Pini-CTO	Milano	Milan

Sponsors (1)

Lead Sponsor	Collaborator
University of Milan

Country where clinical trial is conducted

Italy, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The researchers will calculate the prevalence of BMLs in knee MRI and calculate the intra-observer and inter-observer reliability of the new classification proposed.	This study proposes a topographic classification for knee BMLs consisting in 5 different types of lesions. the classification proposed will be validated by 3 independent researchers.	The lesions will be evaluated on knee MRI performed in the period between January 2017 to December 2018